mRNA vaccines for zoonotic and veterinary diseases: translational barriers, delivery innovations, and strategic integration within the One Health framework

Zoonotic and endemic veterinary diseases remain important constraints on food security, public health, and pandemic preparedness. Conventional vaccine platforms, including live-attenuated, inactivated, and subunit vaccines, may require substantial development time and can have limited flexibility when new pathogens emerge. mRNA vaccines offer an alternative platform with potential advantages in rapidly developing and modifying vaccines against veterinary and zoonotic diseases. Advances in cap engineering, untranslated region optimization, codon design, and nucleoside modification have enhanced antigen expression while reducing undesirable innate immune activation. Self-amplifying RNA platforms may further reduce antigen requirements through intracellular RNA amplification, thereby lowering manufacturing costs. However, translating these technologies from human to veterinary medicine involves several species- and application-specific constraints. Lipid nanoparticle delivery remains inefficient, with reported endosomal escape rates of approximately 1–2%. Pre-existing anti-PEG immunity and species-dependent pharmacokinetic characteristics may affect repeated administration in livestock. Adequate thermostability is also important for field deployment, particularly where cold-chain infrastructure is limited. In addition, DIVA compatibility requirements and differences among regulatory frameworks, including those of the USDA, EMA-CVMP, and national authorities, may complicate product development and approval. This review examines the molecular, immunological, manufacturing, and regulatory evidence relevant to mRNA vaccination against four priority veterinary and zoonotic pathogens: African swine fever virus, porcine reproductive and respiratory syndrome virus, animal coronaviruses, and pestiviruses. These case studies are used to examine the principal translational constraints currently affecting veterinary mRNA vaccine development. The review also considers the potential application of artificial intelligence-assisted antigen design, decentralized manufacturing, and broadly protective vaccine strategies to translate mRNA technology from human medicine to veterinary and One Health applications.

Authors

Institutions

Publication Details

Journal
Frontiers in Veterinary Science
Published
2026-11-17
DOI
https://doi.org/10.3389/fvets.2026.1971000
Primary Topic
Animal Virus Infections Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

mRNA vaccines for zoonotic and veterinary diseases: translational barriers, delivery innovations, and strategic integration within the One Health framework

Mohamed Tharwat, Muhammad Haris, Sohail Ahmed, Aftab Shaukat et al.
1 links
Frontiers in Veterinary Science
Animal Virus Infections Studies
article

mRNA vaccines for zoonotic and veterinary diseases: translational barriers, delivery innovations, and strategic integration within the One Health framework

Mohamed Tharwat, Muhammad Haris, Sohail Ahmed, Aftab Shaukat, Abdulaziz Mohammed Almuzaini, Muhammad Shoaib MAQBOOL, Muhammad Shahzaib Ashfaq
article en

Abstract

Zoonotic and endemic veterinary diseases remain important constraints on food security, public health, and pandemic preparedness. Conventional vaccine platforms, including live-attenuated, inactivated, and subunit vaccines, may require substantial development time and can have limited flexibility when new pathogens emerge. mRNA vaccines offer an alternative platform with potential advantages in rapidly developing and modifying vaccines against veterinary and zoonotic diseases. Advances in cap engineering, untranslated region optimization, codon design, and nucleoside modification have enhanced antigen expression while reducing undesirable innate immune activation. Self-amplifying RNA platforms may further reduce antigen requirements through intracellular RNA amplification, thereby lowering manufacturing costs. However, translating these technologies from human to veterinary medicine involves several species- and application-specific constraints. Lipid nanoparticle delivery remains inefficient, with reported endosomal escape rates of approximately 1–2%. Pre-existing anti-PEG immunity and species-dependent pharmacokinetic characteristics may affect repeated administration in livestock. Adequate thermostability is also important for field deployment, particularly where cold-chain infrastructure is limited. In addition, DIVA compatibility requirements and differences among regulatory frameworks, including those of the USDA, EMA-CVMP, and national authorities, may complicate product development and approval. This review examines the molecular, immunological, manufacturing, and regulatory evidence relevant to mRNA vaccination against four priority veterinary and zoonotic pathogens: African swine fever virus, porcine reproductive and respiratory syndrome virus, animal coronaviruses, and pestiviruses. These case studies are used to examine the principal translational constraints currently affecting veterinary mRNA vaccine development. The review also considers the potential application of artificial intelligence-assisted antigen design, decentralized manufacturing, and broadly protective vaccine strategies to translate mRNA technology from human medicine to veterinary and One Health applications.

Frontiers in Veterinary ScienceVol. 13
Qassim University (SA), Anhui University of Science and Technology (CN), Zagazig University (EG), Hunan University of Arts and Science (CN), Anhui Science and Technology University (CN), University of Faisalabad (PK), University of Poonch Rawalakot (PK), University of Agriculture Faisalabad (PK)
Qassim University
Good health and well-being
Animal Virus Infections Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon